リピディル情報サイト -エビデンスその他-

科研製薬株式会社　KAKEN PHARMACEUTICAL CO.,LTD.

	※ここから先はリンクです。

●UKLDS（the Lipids in Diabetes Study）

●	UKLDS Website
	Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism

●	Combination Statin and Fibrate Therapy in Type 2 Diabetes:Results from the Lipids in Diabetes Study
	Neil A, et al.:Diabetes,52 supplement(1):A74,2003.

●	Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.
	Clarke PM, et al.:Diabetes Care,29(7):1506,2006.

●ACCORD（Action to Control Cardiovascular Risk in Diabetes）

●	ACCORD Lipid 試験インタビュー記録：ACCORD Lipid 試験結果から学ぶこと（東京大学大学院医学系研究科糖尿病・代謝内科　教授　門脇孝先生）

●	Monthlyミクス速報：American College of Cardiology 第59回米国心臓学会議 March 14-16,2010 ACCORD Lipid試験ハイリスク2型糖尿病患者に対するフェノフィブラート＋スタチン併用療法がもたらすもの

●	ACCORD Trial Website

●	Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD

●	Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods The ACCORD Study Group：American Journal of Cardiology, 2007, 99(12A) 21i-33i

●	Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus The ACCORD Study Group：New England Journal of Medicine, 2010, 362 (17) 1563-74

●	Rationale, Design, and Methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE) The ACCORD Study Group：American Journal of Cardiology, 2007, 99(12A) 103i-111i

●	Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes The ACCORD Study Group and ACCORD Eye Study Group：New England Journal of Medicine, 2010, 363 (3) 233-44

●SAFARI

●	Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
	Grundy SM, et al.:Am J Cardiol,95(4):462,2005.

●	Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
	Grundy SM, et al.:Am J Cardiol,104(4):548,2009.

●	Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).
	Grundy SM, et al.:Am J Cardiol,108(1):40,2011.

科研製薬ウェブサイトにおける個人情報等の取り扱いについて｜お問い合わせ｜科研製薬株式会社